A New Chapter in an Ancient Story

Testing a Traditional Remedy for COVID-19

Clinical Trial Traditional Medicine COVID-19 Research

The Big Question: Can an Ancient Formula Fight a Modern Virus?

Imagine a health challenge that circles the globe, changing the way we live, work, and connect. COVID-19, the disease caused by the SARS-CoV-2 virus, has been exactly that. While modern science raced to create powerful vaccines and antivirals, researchers have also been looking back—way back—for potential solutions.

Modern Challenge

COVID-19 has presented unprecedented global health challenges, driving innovation across all medical disciplines.

Ancient Wisdom

Traditional Chinese Medicine offers centuries of accumulated knowledge about treating respiratory illnesses.

"The core idea behind using TCM for COVID-19 isn't about magic bullets, but about holistic support. Formulas like SanHanHuaShi are designed not necessarily to kill the virus directly, but to help the body restore its natural balance and mount a more effective defense."

The Scientific Detective Work: Blueprint for a Clinical Trial

To answer their big question, scientists have designed a detective story with the most rigorous rules possible. Here's a visual guide to their methodology:

1. Protocol Design

Creating a detailed research plan that outlines every aspect of the study before it begins.

2. Participant Recruitment

Identifying and screening eligible patients who match the study criteria.

3. Randomization

Assigning participants randomly to either the treatment or control group.

4. Intervention

Administering the SanHanHuaShi granules to the treatment group for 7 days.

5. Data Collection

Monitoring symptoms, viral load, and safety parameters throughout the study.

6. Statistical Analysis

Comparing outcomes between groups using pre-specified statistical methods.

Randomized

Participants randomly assigned to groups to eliminate bias

Controlled

Direct comparison between treatment and control groups

Open-Label

Both researchers and participants know which treatment is being administered

Gathering the Participants

The study will recruit hundreds of eligible patients who have tested positive for COVID-19 and match the specific TCM syndrome. To ensure a fair test, they must meet clear criteria.

Inclusion Criteria
  • Adult aged 18-80
  • Positive PCR test
  • Symptoms matching the "cold-dampness" syndrome
  • Onset of illness within the last 3 days
Exclusion Criteria
  • Severe or critical COVID-19
  • Allergies to the study medication
  • Pregnant or breastfeeding
  • Already taking other unapproved COVID drugs
Participant Distribution

The Treatment Regimen

SanHanHuaShi Granules

Traditional Formula in Modern Form

The Test Group takes the SanHanHuaShi granules, dissolved in warm water, twice a day for 7 days. Both groups receive the same standard medical care recommended by national guidelines.

Dosage Schedule
Twice Daily 7 Days With Standard Care
Study Groups
Test Group

Receives Standard Care + SanHanHuaShi Granules

Control Group

Receives Standard Care Only

TCM Syndrome: "Cold-Dampness"

Patients with this condition often experience:

Fever Feeling Cold Body Aches Coughing

Measuring What Matters: The Endpoints

How do you measure "effectiveness"? The researchers have pre-specified clear targets, known as endpoints.

Primary Endpoint
Time for Symptom Resolution

Time for all core symptoms (fever, fatigue, cough) to return to normal.

Main Outcome Measure
Secondary Endpoints
  • Rate of disease progression to severe/critical COVID-19
  • The amount of virus detected in the body (viral load)
  • Use of other medications or therapies
Expected Outcomes Visualization

A Bridge Between Traditions

This clinical trial is more than just testing a single medicine. It represents a bridge between ancient healing traditions and the rigorous demands of modern evidence-based science.

Ancient Wisdom

Centuries of Traditional Chinese Medicine knowledge

Modern Science

Rigorous clinical trial methodology and statistical analysis

Integration

Creating a blueprint for evaluating traditional medicines

By applying a structured, transparent, and controlled protocol, researchers are not just validating a potential new treatment option for COVID-19; they are creating a blueprint for how to respectfully and scientifically evaluate the vast pharmacopeia of traditional medicines.